HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAF<sup>V600E</sup>-mutant microsatellite stable colorectal cancer
Zhuang Sun(Affiliated Zhongshan Hospital of Dalian University), Jin Gu(Peking University Shougang Hospital)
Cited by 9
Related Papers
MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1
|Molecular Cancer|2014|151
Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer
|Theranostics|2017|77
Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer
|Journal of Translational Medicine|2024|50
Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus
|Chinese Medical Journal|2023|16
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
|Holistic Integrative Oncology|2023|12